Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Assertio Therapeutics, Inc (DEPO) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Assertio Therapeutics, Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1005201.
Total stock buying since 2014: $1,069,823.
Total stock sales since 2014: $7,879,464.
Total stock option exercises since 2014: $4,349,045.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2020 | 0 | $0 | 15,834 | $12,524 | 273,943 | $0 |
| 2019 | 189,900 | $309,023 | 25,000 | $98,500 | 338,626 | $0 |
| 2018 | 0 | $0 | 83,614 | $520,023 | 49,861 | $22,350 |
| 2017 | 90,000 | $760,800 | 311,599 | $3,211,594 | 260,820 | $1,326,446 |
| 2016 | 0 | $0 | 115,540 | $2,216,816 | 59,495 | $429,935 |
| 2015 | 0 | $0 | 20,000 | $374,475 | 224,315 | $1,277,229 |
| 2014 | 0 | $0 | 93,405 | $1,445,532 | 224,740 | $1,293,085 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2020-05 | 0 | $0 | 15,834 | $12,524 | 0 | $0 |
| 2020-04 | 0 | $0 | 0 | $0 | 25,370 | $0 |
| 2020-03 | 0 | $0 | 0 | $0 | 12,492 | $0 |
| 2020-02 | 0 | $0 | 0 | $0 | 236,081 | $0 |
| 2019-12 | 0 | $0 | 0 | $0 | 43,219 | $0 |
| 2019-11 | 48,900 | $35,420 | 0 | $0 | 0 | $0 |
| 2019-09 | 0 | $0 | 0 | $0 | 11,623 | $0 |
| 2019-08 | 120,000 | $186,169 | 0 | $0 | 1,814 | $0 |
| 2019-06 | 0 | $0 | 12,500 | $39,800 | 0 | $0 |
| 2019-05 | 0 | $0 | 12,500 | $58,700 | 187,500 | $0 |
| 2019-04 | 0 | $0 | 0 | $0 | 25,370 | $0 |
| 2019-03 | 21,000 | $87,434 | 0 | $0 | 0 | $0 |
| 2019-02 | 0 | $0 | 0 | $0 | 69,100 | $0 |
| 2018-12 | 0 | $0 | 18,421 | $81,413 | 49,861 | $22,350 |
| 2018-05 | 0 | $0 | 19,674 | $139,095 | 0 | $0 |
| 2018-03 | 0 | $0 | 45,519 | $299,515 | 0 | $0 |
| 2017-12 | 75,000 | $612,000 | 0 | $0 | 15,000 | $22,350 |
| 2017-06 | 15,000 | $148,800 | 202,387 | $1,937,045 | 160,820 | $1,048,546 |
| 2017-05 | 0 | $0 | 109,212 | $1,274,549 | 0 | $0 |
| 2017-03 | 0 | $0 | 0 | $0 | 15,000 | $49,050 |
| 2017-02 | 0 | $0 | 0 | $0 | 70,000 | $206,500 |
| 2016-11 | 0 | $0 | 5,000 | $104,200 | 5,000 | $63,450 |
| 2016-09 | 0 | $0 | 11,250 | $281,250 | 0 | $0 |
| 2016-08 | 0 | $0 | 31,290 | $656,986 | 3,297 | $41,838 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-05-08 | Dawes Karen A | Sale | 15,834 | .79 | 12,524 |
| 2020-04-02 | Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) | Option Ex | 25,370 | .00 | 0 |
| 2020-03-30 | Galeota James Jr | Option Ex | 12,492 | .00 | 0 |
| 2020-02-18 | Mason Heather L | Option Ex | 14,394 | .00 | 0 |
| 2020-02-12 | Peisert Daniel A. (SVP and CFO) | Option Ex | 27,588 | .00 | 0 |
| 2020-02-12 | Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) | Option Ex | 27,588 | .00 | 0 |
| 2020-02-12 | Higgins Arthur J (Director, President and CEO) | Option Ex | 97,412 | .00 | 0 |
| 2020-02-06 | Peisert Daniel A. (SVP and CFO) | Option Ex | 6,700 | .00 | 0 |
| 2020-02-06 | Higgins Arthur J (Director, President and CEO) | Option Ex | 62,399 | .00 | 0 |
| 2019-12-01 | Peisert Daniel A. (SVP and CFO) | Option Ex | 8,359 | .00 | 0 |
| 2019-12-01 | Higgins Arthur J (Director, President and CEO) | Option Ex | 34,860 | .00 | 0 |
| 2019-11-12 | Higgins Arthur J (Director, President and CEO) | Buy | 25,000 | .73 | 18,250 |
| 2019-11-11 | Peisert Daniel A. (SVP and CFO) | Buy | 10,000 | .73 | 7,260 |
| 2019-11-11 | Staple Peter D | Buy | 13,900 | .71 | 9,910 |
| 2019-09-18 | Peisert Daniel A. (SVP and CFO) | Option Ex | 11,623 | .00 | 0 |
| 2019-08-20 | Peisert Daniel A. (SVP and CFO) | Buy | 14,000 | 1.49 | 20,790 |
| 2019-08-19 | Higgins Arthur J (Director, President and CEO) | Buy | 25,000 | 1.61 | 40,250 |
| 2019-08-15 | Peisert Daniel A. (SVP and CFO) | Option Ex | 1,814 | .00 | 0 |
| 2019-08-13 | Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) | Buy | 8,000 | 1.56 | 12,456 |
| 2019-08-12 | Peisert Daniel A. (SVP and CFO) | Buy | 19,000 | 1.55 | 29,545 |
| 2019-08-12 | Higgins Arthur J (Director, President and CEO) | Buy | 50,000 | 1.54 | 76,900 |
| 2019-06-13 | Dawes Karen A | Sale | 12,500 | 3.18 | 39,800 |
| 2019-05-09 | Mckee William | Sale | 12,500 | 4.70 | 58,700 |
| 2019-05-08 | Tyree James L | Option Ex | 31,250 | .00 | 0 |
| 2019-05-08 | Staple Peter D | Option Ex | 31,250 | .00 | 0 |
| 2019-05-08 | Dawes Karen A | Option Ex | 31,250 | .00 | 0 |
| 2019-05-08 | Mckee William | Option Ex | 31,250 | .00 | 0 |
| 2019-05-08 | Fogarty James P | Option Ex | 31,250 | .00 | 0 |
| 2019-05-07 | Lavigne Louis J Jr | Option Ex | 31,250 | .00 | 0 |
| 2019-04-02 | Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) | Option Ex | 25,370 | .00 | 0 |
| 2019-03-14 | Peisert Daniel A. (SVP and CFO) | Buy | 6,000 | 4.18 | 25,074 |
| 2019-03-14 | Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) | Buy | 5,000 | 4.13 | 20,660 |
| 2019-03-14 | Higgins Arthur J (Director, President and CEO) | Buy | 10,000 | 4.17 | 41,700 |
| 2019-02-06 | Peisert Daniel A. (SVP and CFO) | Option Ex | 6,700 | .00 | 0 |
| 2019-02-06 | Higgins Arthur J (Director, President and CEO) | Option Ex | 62,400 | .00 | 0 |
| 2018-12-14 | Mckee William | Sale | 10,000 | 4.07 | 40,690 |
| 2018-12-03 | Dawes Karen A | Sale | 8,421 | 4.84 | 40,723 |
| 2018-12-03 | Dawes Karen A | Option Ex | 15,000 | 1.49 | 22,350 |
| 2018-12-01 | Higgins Arthur J (Director, President and CEO) | Option Ex | 34,861 | .00 | 0 |
| 2018-05-11 | Gosling Matthew M (SVP, General Counsel) | Sale | 19,674 | 7.07 | 139,095 |
| 2018-03-07 | Gosling Matthew M (SVP, General Counsel) | Sale | 45,519 | 6.58 | 299,515 |
| 2017-12-14 | Higgins Arthur J (President and CEO) | Buy | 75,000 | 8.16 | 612,000 |
| 2017-12-01 | Staple Peter D | Option Ex | 15,000 | 1.49 | 22,350 |
| 2017-06-13 | Vargas Thadd M (SVP, Business Development) | Sale | 202,387 | 9.57 | 1,937,045 |
| 2017-06-13 | Vargas Thadd M (SVP, Business Development) | Option Ex | 160,820 | 6.52 | 1,048,546 |
| 2017-06-12 | Higgins Arthur J (President and CEO) | Buy | 15,000 | 9.92 | 148,800 |
| 2017-05-11 | Vargas Thadd M (Senior VP, BD) | Sale | 50,000 | 12.03 | 601,250 |
| 2017-05-11 | Gosling Matthew M (SVP, General Counsel) | Sale | 59,212 | 11.37 | 673,299 |
| 2017-03-31 | Staple Peter D | Option Ex | 15,000 | 3.27 | 49,050 |
| 2017-02-21 | Zenoff David B | Option Ex | 70,000 | 2.95 | 206,500 |
| 2016-11-14 | Moretti August J (Chief Financial Officer & SVP) | Sale | 5,000 | 20.84 | 104,200 |
| 2016-11-14 | Moretti August J (Chief Financial Officer & SVP) | Option Ex | 5,000 | 12.69 | 63,450 |
| 2016-09-21 | Vargas Thadd M (Senior VP, BD) | Sale | 11,250 | 25.00 | 281,250 |
| 2016-08-10 | Vargas Thadd M (Senior VP, BD) | Sale | 26,290 | 20.92 | 549,986 |
| 2016-08-10 | Moretti August J (Chief Financial Officer & SVP) | Sale | 5,000 | 21.40 | 107,000 |
| 2016-08-10 | Moretti August J (Chief Financial Officer & SVP) | Option Ex | 3,297 | 12.69 | 41,838 |
| 2016-05-23 | Vargas Thadd M (Senior VP, BD) | Sale | 15,000 | 20.00 | 300,000 |
| 2016-05-10 | Vargas Thadd M (Senior VP, BD) | Sale | 15,000 | 17.64 | 264,600 |
| 2016-05-09 | Moretti August J (Chief Financial Officer & SVP) | Sale | 5,000 | 18.00 | 90,000 |
| 2016-03-18 | Schoeneck James A (President and CEO) | Option Ex | 30,483 | 5.42 | 165,217 |
| 2016-03-11 | Vargas Thadd M (Senior VP, BD) | Sale | 23,000 | 16.00 | 368,000 |
| 2016-03-08 | Srinivas G. Rao (SVP and Chief Medical Officer) | Option Ex | 2,535 | 11.83 | 29,989 |
| 2016-03-02 | Vargas Thadd M (SVP, Business Development) | Sale | 10,000 | 15.18 | 151,780 |
| 2016-01-11 | Vargas Thadd M (SVP, Business Development) | Option Ex | 18,180 | 7.12 | 129,441 |
| 2015-12-28 | Schoeneck James A (President and CEO) | Option Ex | 6,365 | 6.11 | 38,890 |
| 2015-12-16 | Moretti August J (Chief Financial Officer & SVP) | Option Ex | 5,000 | 5.35 | 26,750 |
| 2015-12-03 | Moretti August J (Chief Financial Officer & SVP) | Sale | 15,000 | 18.07 | 270,975 |
| 2015-09-30 | Staple Peter D | Option Ex | 20,000 | 4.74 | 94,800 |
| 2015-09-29 | Schoeneck James A (President and CEO) | Option Ex | 63,561 | 6.44 | 409,332 |
| 2015-06-12 | Vargas Thadd M (Senior VP, BD) | Sale | 5,000 | 20.70 | 103,500 |
| 2015-05-12 | Schoeneck James A (President and CEO) | Option Ex | 45,679 | 6.86 | 313,357 |
| 2015-05-12 | Staple Peter D | Option Ex | 10,000 | 6.18 | 61,800 |
| 2015-04-08 | Vargas Thadd M (Senior VP, BD) | Option Ex | 54,710 | 4.33 | 236,730 |
| 2015-01-20 | Vargas Thadd M (Senior VP, BD) | Option Ex | 19,000 | 5.03 | 95,570 |
| 2014-12-19 | Schoeneck James A (President and CEO) | Option Ex | 40,700 | 8.36 | 340,252 |
| 2014-12-02 | Vargas Thadd M (Senior VP, BD) | Sale | 8,247 | 15.85 | 130,739 |
| 2014-12-02 | Gosling Matthew M (Senior VP, General Counsel) | Sale | 8,819 | 15.85 | 139,807 |
| 2014-12-02 | Moretti August J (Chief Financial Officer) | Sale | 5,339 | 15.85 | 84,639 |
| 2014-11-25 | Staple Peter D | Option Ex | 10,000 | 5.04 | 50,400 |
| 2014-11-19 | Gosling Matthew M (Senior VP, General Counsel) | Sale | 71,000 | 15.36 | 1,090,347 |
| 2014-11-19 | Gosling Matthew M (Senior VP, General Counsel) | Option Ex | 71,000 | 6.17 | 438,070 |
| 2014-08-01 | Schoeneck James A (President and CEO) | Option Ex | 30,000 | 6.11 | 183,300 |
| 2014-05-16 | Vargas Thadd M (Senior VP, BD) | Option Ex | 39,040 | 3.09 | 120,633 |
| 2014-05-09 | Schoeneck James A (President and CEO) | Option Ex | 30,000 | 4.53 | 135,750 |
| 2014-05-09 | Gosling Matthew M (Senior VP, General Counsel) | Option Ex | 4,000 | 6.17 | 24,680 |
Insider trading activities including stock purchases, stock sales, and option exercises of DEPO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Assertio Therapeutics, Inc (symbol DEPO, CIK number 1005201) see the Securities and Exchange Commission (SEC) website.